BMD Alterations and Bone and Muscle Parameters During Menstrual Cessation With GnRH

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

December 1, 2020

Study Completion Date

December 31, 2020

Conditions

EndometriosisBone DensityMuscleBone Metabolism

Interventions

DRUG

Goserelin Acetate

Goserelin the a GnRH analog that will be administered to achieve menstrual cessation for 6 months

Trial Locations (1)

424 General Military Hospital, Thessaloniki

All Listed Sponsors

collaborator

251 Hellenic Air Force & VA General Hospital

OTHER

collaborator

Aristotle University Of Thessaloniki

OTHER

lead

424 General Military Hospital

OTHER

NCT04203212 - BMD Alterations and Bone and Muscle Parameters During Menstrual Cessation With GnRH | Biotech Hunter | Biotech Hunter